We read the new risks in every 10-K, 10-Q and 20-F and separate concrete facts (countries, customers, figures, regulations or events) from generic wording that adds nothing. Rewording doesn't count.
| Company | Filing | Concrete risks | Themes | Reason |
|---|---|---|---|---|
| NVDA NVIDIA CORP | 10-Q 2026-08-26 | 3 | Customers and competitionDebt and liquidityCorporate transactions | 3 concrete new risks (customers and competition, debt and liquidity, corporate transactions) |
| SNDK Sandisk Corp | 10-K 2026-08-17 | 9 | Customers and competitionCorporate transactionsTechnology and products | 9 concrete new risks (customers and competition, corporate transactions, technology and products) |
| RKLB Rocket Lab Corp | 10-Q 2026-08-10 | 17 | LitigationRegulationCorporate transactions | 17 concrete new risks (litigation, regulation, corporate transactions) |
| KDP Keurig Dr Pepper Inc. | 10-Q 2026-08-10 | 12 | Supply chainCorporate transactionsGeopolitics and conflict | 12 concrete new risks (supply chain, corporate transactions, geopolitics and conflict) |
| VRTX VERTEX PHARMACEUTICALS INC / MA | 10-Q 2026-08-04 | 2 | Corporate transactions | 2 concrete new risks (corporate transactions) |
| CMCSA COMCAST CORP | 10-Q 2026-07-23 | 1 | Corporate transactions | 1 concrete new risk (corporate transactions) |
| FER Ferrovial N.V. | 20-F 2026-02-25 | 10 | LitigationCustomers and competitionGeopolitics and conflict | 10 concrete new risks (litigation, customers and competition, geopolitics and conflict) |
With Pro you see every new risk in each filing, with concrete facts separated from generic wording.
Go Pro a recent important 8-K, or the company states as a fact (not a hypothesis) going-concern doubts, a weakness in internal control or a listing notice ·
new risks describing concrete facts ·
nothing relevant new.
Source: SEC EDGAR. A language model run on our own servers classifies each new risk by reading its context; it can make mistakes, so always check the original document. For information purposes only; not investment advice.